Stockscreener 앱 받기
5.14
3.63%
0.1799
시간 외 거래:
5.00
-0.14
-2.72%
전일 마감가:
$4.9601
열려 있는:
$5
하루 거래량:
7,470
Relative Volume:
0.07
시가총액:
$6.38M
수익:
-
순이익/손실:
$-7.03M
주가수익비율:
-0.5767
EPS:
-8.9134
순현금흐름:
$-8.20M
1주 성능:
-0.58%
1개월 성능:
+48.13%
6개월 성능:
-30.63%
1년 성능:
+62.66%
1일 변동 폭
$4.916
$5.16
1주일 범위
$4.74
$5.38
52주 변동 폭
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
명칭
Endra Life Sciences Inc
전화
734-335-0468
주소
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
5.14 | 6.15M | 0 | -7.03M | -8.20M | -8.9134 |
TMO
Thermo Fisher Scientific Inc
|
531.67 | 195.93B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
198.14 | 140.56B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
580.76 | 46.39B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
119.77 | 34.02B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
326.20 | 32.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Endra Life Sciences Inc 주식(NDRA)의 최신 뉴스
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS Registered Liver Imaging Technology - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology - Barchart.com
Aug Fed Impact: What is the PEG ratio of ENDRA Life Sciences IncMarket Movers & Fast Momentum Entry Tips - baoquankhu1.vn
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
Aug Fed Impact: Whats the MACD signal for ENDRA Life Sciences IncGDP Growth & Long-Term Safe Investment Ideas - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside - Barchart
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 - openPR.com
Retail Surge: Is ENDRA Life Sciences Inc exposed to currency risks2026 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - FinancialContent
ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView — Track All Markets
ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - GuruFocus
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) flags going-concern risk and pivots to digital asset treasury - Stock Titan
ENDRA Life Sciences | 8-K: ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Moomoo
ENDRA Life Sciences Q4 net loss narrows - TradingView — Track All Markets
Form 8-KCurrent report - ADVFN
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - ChartMill
Day Trade: Whats the MACD signal for ENDRA Life Sciences Inc2026 Market Overview & Daily Entry Point Alerts - baoquankhu1.vn
ENDRA Life Sciences (NASDAQ: NDRA) cuts 2025 operating costs sharply - Stock Titan
Movement Recap: Does ENDRA Life Sciences Inc outperform in volatile marketsWeekly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
ENDRA Life Sciences (NDRA) Expected to Announce Earnings on Monday - National Today
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
NDRA Ignites: 20% Surge Signals Strategic Overhaul as Capital Hunt for Micro-Cap Alphas - Bitget
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
ENDRA Life Sciences Explores Strategic Alternatives Amid Restructuring - The Globe and Mail
ENDRA Life Sciences explores strategic alternatives By Investing.com - in.investing.com
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside - FinancialContent
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value - BioSpace
Strategic options review launched by ENDRA Life Sciences (Nasdaq: NDRA) - Stock Titan
ENDRA Life Sciences explores strategic alternatives - Investing.com
ENDRA (NDRA) Explores Strategic Options to Enhance Shareholder V - GuruFocus
ENDRA Life Sciences Inc. Initiates Review of Strategic Alternatives to Maximize Shareholder Value - marketscreener.com
ENDRA Life Sciences Inc announced that its Board of Directors has initiated a strategic review process aimed at a comprehensive assessment of the company’s future development pathways. - Bitget
ENDRA Life Sciences (NDRA) Expected to Announce Quarterly Earnings on Monday - Defense World
If You Invested $1,000 in Endra Life Sciences Inc (NDRA) - Stock Titan
Tech Rally: Is ENDRA Life Sciences Inc being accumulated by smart money2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Stocks Under $10: IBRX, VTIX, NDRA, SMX2026 Watch Now! - openPR.com
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - The Norfolk Daily News
IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - FinancialContent
ENDRA Life Sciences (NASDAQ: NDRA) - MarketScreener
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play In The $100B+MASH+GLP-1 Healthcare Boom - Mena FN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
User - The Chronicle-Journal
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now! - Barchart.com
FinancialContentFavorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - FinancialContent
Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA - FinancialContent
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - Barchart
Favorable Results on Liver Device for Long-Term Monitoring - openPR.com
Endra Life Sciences Inc (NDRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.41%
1.61%
자본화:
|
볼륨(24시간):